Krell J
An open-label study evaluating the efficacy and tolerability of alefacept for the treatment of scalp psoriasis
J Am Acad Dermatol. 2008 Apr;58(4):609-16

Papadavid E
Palmoplantar and scalp psoriasis occurring during anti-tumour necrosis factor-alpha therapy: a case series of four patients and guidelines for management
J Eur Acad Dermatol Venereol. 2008 Mar;22(3):380-2

Berg M
Psoriasis and stress: A prospective study
J Eur Acad Dermatol Venereol. 2008 Mar 18

Kimball AB
National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening
J Am Acad Dermatol. 2008 Feb 27

Kimball AB
Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial
Arch Dermatol. 2008 Feb;144(2):200-7

Lindqvist UR
The Swedish Early Psoriatic Arthritis Register -- 2-year Followup: A Comparison with Early Rheumatoid Arthritis
J Rheumatol. 2008 Feb 15

Schöffski O
Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study
J Dtsch Dermatol Ges. 2007 Mar;5(3):209-18

Weiss SC
An assessment of the cost-utility of therapy for psoriasis
Ther Clin Risk Manag. 2006 Sep;2(3):325-8

Bissonnette R
A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis
J Am Acad Dermatol. 2006 Mar;54(3):472-8